Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  Ischemic Heart Disease

  Free Subscription


16 Am J Cardiol
1 Am J Med
2 Angiology
9 Atherosclerosis
2 Can J Cardiol
2 Circ Cardiovasc Qual Outcomes
8 Circulation
2 Clin Cardiol
10 Eur Heart J
1 Int J Cardiol
5 J Am Coll Cardiol
4 J Cardiovasc Pharmacol
4 J Clin Endocrinol Metab
1 J Clin Epidemiol
2 J Nucl Med
1 J Thorac Cardiovasc Surg
2 Mayo Clin Proc
2 Mol Cell Biochem
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. ANDO G, Gragnano F, Pelliccia F, Calabro P, et al
    Choice of P2Y(12) inhibitors after acute coronary syndrome.
    Am J Cardiol. 2023 Nov 7:S0002-9149(23)01262.

  2. TAN MC, Yeo YH, Ibrahim R, Tan MX, et al
    Trends and Disparities in Cardiovascular Death in Non-Hodgkin Lymphoma.
    Am J Cardiol. 2023 Sep 30:S0002-9149(23)01023.

  3. JANG MH, Kim AR, Kim T, Oh HJ, et al
    Age- and Sex-Specific Disparities in Outcomes After Ticagrelor Versus Clopidogrel in East Asian Patients.
    Am J Cardiol. 2023;207:237-244.
    PubMed         Abstract available

  4. ELAD B, Aronson D, Cohn-Schwartz D, Kapeliovich M, et al
    Diagnostic Value of High-Sensitivity Cardiac Troponin-I in Patients After Out-of-Hospital Cardiac Arrest.
    Am J Cardiol. 2023;207:253-256.
    PubMed         Abstract available

  5. GANNON MP, Cerci RJ, Valdiviezo C, Ostovaneh MR, et al
    Combined Computed Tomography Angiography-Computed Tomography Perfusion in the Identification and Prognostic Assessment of Myocardial Bridging from the CORE320 Study: 5-Year Follow-Up.
    Am J Cardiol. 2023;207:314-321.
    PubMed         Abstract available

    Coronary Bifurcation Intervention: Simpler Should Be Better?
    Am J Cardiol. 2023;207:520.

  7. LEE HH, Jang WJ, Ahn CM, Chun WJ, et al
    Association of Prophylactic Distal Perfusion Cannulation With Mortality in Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation.
    Am J Cardiol. 2023;207:418-425.
    PubMed         Abstract available

  8. RUSNAK J, Schupp T, Weidner K, Ruka M, et al
    Outcome of Patients With Cardiogenic Shock and Previous Right Ventricular Impairment Represented by Decreased Tricuspid Annular Plane Systolic Excursion and Tricuspid Annular Plane Systolic Excursion to Pulmonary Artery Systolic Pressure Ratio.
    Am J Cardiol. 2023;207:431-440.
    PubMed         Abstract available

  9. SAITO T, Shiono Y, Nagamine S, Fujita M, et al
    Prognostic Values of Fractional Flow Reserve Based on Clinical Outcomes in Patients on Chronic Hemodialysis.
    Am J Cardiol. 2023;207:441-447.
    PubMed         Abstract available

  10. NAZIR MS, Murphy T, Poku N, Wheen P, et al
    Clinical Utility and Prognostic Value of Coronary Computed Tomography Angiography in Patients With Cancer.
    Am J Cardiol. 2023;207:448-454.
    PubMed         Abstract available

    Management of re-stenosis.
    Am J Cardiol. 2023;207:455.

  12. LOWE CM, Seto AH
    Exploring the Impact of End-Stage Renal Disease on Fractional Flow Reserve.
    Am J Cardiol. 2023;207:505-506.

  13. SHIRAFKAN A, Gidea CG, Stein LH
    Commentary: Myocarditis, Shock, and Extracorporeal Life Support, a Significant Story Revealing the Unexpected.
    Am J Cardiol. 2023;207:511-512.

  14. KARLSSON E, Kiviniemi T, Halminen O, Lehtonen O, et al
    Temporal Relation Between Myocardial Infarction And New-onset Atrial Fibrillation - Results From a Nationwide Registry Study.
    Am J Cardiol. 2023 Nov 2:S0002-9149(23)01240.
    PubMed         Abstract available

  15. SEN F, Kurtul A, Bekler O
    Pan-Immune-Inflammation Value is Independently Correlated to Impaired Coronary Flow After Primary PCI in Patients With ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2023 Nov 7:S0002-9149(23)01297.
    PubMed         Abstract available

  16. SAADI RP, Tagliari AP, Tang GHL
    Is Transcatheter Aortic Valve Replacement the New Percutaneous Coronary Intervention? Insights from the Japanese Experience.
    Am J Cardiol. 2023 Oct 20:S0002-9149(23)01186.

    Am J Med

  17. MATHEW RO, Kretov EI, Huang Z, Jones PG, et al
    BMI and Clinical and Health Status Outcomes in Chronic Coronary Disease and Advanced Kidney Disease in ISCHEMIA-CKD.
    Am J Med. 2023 Nov 2:S0002-9343(23)00674-5. doi: 10.1016/j.amjmed.2023.
    PubMed         Abstract available


  18. WANG X, Guo R, Huang M, Li Z, et al
    Fibrinogen-to-Albumin Ratio and Glucose Metabolic States in Patients With Coronary Heart Disease.
    Angiology. 2023 Nov 8:33197231206235. doi: 10.1177/00033197231206235.
    PubMed         Abstract available

  19. WANG J, Zhang F, Liu L, Gao M, et al
    Prognostic Value of GRACE Risk Score Combined With Systemic Immune-Inflammation Index in Patients With ST-Segment Elevation Myocardial Infarction After Percutaneous Coronary Intervention.
    Angiology. 2023 Nov 7:33197231213674. doi: 10.1177/00033197231213674.
    PubMed         Abstract available


  20. CHEDID G, Malik A, Daher R, Welty FK, et al
    Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease.
    Atherosclerosis. 2023;384:117168.
    PubMed         Abstract available

  21. VINK CEM, Woudstra J, Lee JM, Boerhout CKM, et al
    Sex differences in prevalence and outcomes of the different endotypes of chronic coronary syndrome in symptomatic patients undergoing invasive coronary angiography: Insights from the global ILIAS invasive coronary physiology registry.
    Atherosclerosis. 2023 Jul 8:117167. doi: 10.1016/j.atherosclerosis.2023.
    PubMed         Abstract available

  22. KANG J, Cho Y
    Sex differences in the association between minor nonspecific ST-segment and T-wave abnormalities and coronary artery calcification.
    Atherosclerosis. 2023;384:117154.
    PubMed         Abstract available

  23. LU C, Donners MMPC, Karel J, de Boer H, et al
    Sex-specific differences in cytokine signaling pathways in circulating monocytes of cardiovascular disease patients.
    Atherosclerosis. 2023;384:117123.
    PubMed         Abstract available

  24. HOLTZMAN JN, Kaur G, Hansen B, Bushana N, et al
    Sex differences in the management of atherosclerotic cardiovascular disease.
    Atherosclerosis. 2023;384:117268.
    PubMed         Abstract available

  25. GURGOGLIONE FL, Solinas E, Pfleiderer B, Vezzani A, et al
    Coronary atherosclerotic plaque phenotype and physiopathologic mechanisms: Is there an influence of sex? Insights from intracoronary imaging.
    Atherosclerosis. 2023;384:117273.
    PubMed         Abstract available

  26. SAKKERS TR, Mokry M, Civelek M, Erdmann J, et al
    Sex differences in the genetic and molecular mechanisms of coronary artery disease.
    Atherosclerosis. 2023;384:117279.
    PubMed         Abstract available

  27. CIVIERI G, Kerkhof PLM, Montisci R, Iliceto S, et al
    Sex differences in diagnostic modalities of coronary artery disease: Evidence from coronary microcirculation.
    Atherosclerosis. 2023;384:117276.
    PubMed         Abstract available

  28. CROOIJMANS J, Singh S, Naqshband M, Bruikman CS, et al
    Premature atherosclerosis: An analysis over 39 years in the Netherlands. Implications for young individuals in high-risk families.
    Atherosclerosis. 2023;384:117267.
    PubMed         Abstract available

    Can J Cardiol

  29. HU P, Chang J, Huang Y, Guo M, et al
    Nonoptimum Temperatures Are More Closely Associated With Fatal Myocardial Infarction Than With Nonfatal Events.
    Can J Cardiol. 2023 Nov 3:S0828-282X(23)01645-8. doi: 10.1016/j.cjca.2023.
    PubMed         Abstract available

  30. ALKASAB M, Bainey KR
    Clopidogrel Monotherapy in Older Stable Ischemic Heart Disease Patients Receiving Percutaneous Coronary Intervention: A Paradigm Shiftt?
    Can J Cardiol. 2023 Nov 2:S0828-282X(23)01875-5. doi: 10.1016/j.cjca.2023.

    Circ Cardiovasc Qual Outcomes

  31. GIROTRA S, Kumbhani DJ
    Percutaneous Coronary Intervention for Heart Failure: Worth the Cost?
    Circ Cardiovasc Qual Outcomes. 2023 Nov 6. doi: 10.1161/CIRCOUTCOMES.123.010572.

  32. MARINACCI LX, Bartlett V, Zheng Z, Mein S, et al
    Healthcare Access and Cardiovascular Risk Factor Management Among Working-Age US Adults During the Pandemic.
    Circ Cardiovasc Qual Outcomes. 2023 Nov 6. doi: 10.1161/CIRCOUTCOMES.123.010516.
    PubMed         Abstract available


  33. KHAN SS, Coresh J, Pencina MJ, Ndumele CE, et al
    Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Nov 10. doi: 10.1161/CIR.0000000000001191.
    PubMed         Abstract available

  34. KHAN SS, Matsushita K, Sang Y, Ballew SH, et al
    Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations.
    Circulation. 2023 Nov 10. doi: 10.1161/CIRCULATIONAHA.123.067626.
    PubMed         Abstract available

  35. BERG KM, Bray JE, Ng KC, Liley HG, et al
    2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
    Circulation. 2023 Nov 9. doi: 10.1161/CIR.0000000000001179.
    PubMed         Abstract available

  36. GAO L, Zhao Y, Wu H, Lin X, et al
    Polycystic Ovary Syndrome Fuels Cardiovascular Inflammation and Aggravates Ischemic Cardiac Injury.
    Circulation. 2023 Nov 8. doi: 10.1161/CIRCULATIONAHA.123.065827.
    PubMed         Abstract available

  37. LI S, Qian J, Li JJ
    Letter by Li et al Regarding Article, "Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study".
    Circulation. 2023;148:1507-1508.

  38. OGAH OS, Orimolade OA, Jinadu TO
    Cardiovascular Diseases in Nigeria: Current Status, Threats, and Opportunities.
    Circulation. 2023;148:1441-1444.

  39. RIDKER PM, Lei L, Louie MJ, Haddad T, et al
    Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13970 Contemporary High-Risk Patients With Statin Intolerance.
    Circulation. 2023 Nov 6. doi: 10.1161/CIRCULATIONAHA.123.066213.
    PubMed         Abstract available

  40. BAWASKAR P, Thomas N, Ismail KF, Guo Y, et al
    Non-ischemic or Dual Cardiomyopathy in Patients with Coronary Artery Disease.
    Circulation. 2023 Nov 6. doi: 10.1161/CIRCULATIONAHA.123.067032.
    PubMed         Abstract available

    Clin Cardiol

  41. LV H, Li X, Ren Z, Ma X, et al
    Intravascular lithotripsy: A novel option for severe calcification of coronary artery.
    Clin Cardiol. 2023 Nov 9. doi: 10.1002/clc.24186.
    PubMed         Abstract available

  42. GAVINA C, Seabra-Carvalho D, Aguiar C, Anastassopoulou A, et al
    Characterization and LDL-C management in a cohort of high and very high cardiovascular risk patients: The PORTRAIT-DYS study.
    Clin Cardiol. 2023 Nov 6. doi: 10.1002/clc.24183.
    PubMed         Abstract available

    Eur Heart J

  43. COLOMBO A, Leone PP
    Redefining the way to perform percutaneous coronary intervention: a view in search of evidence.
    Eur Heart J. 2023 Apr 11:ehad215. doi: 10.1093.

  44. WANG HY, Zhang R, Dou K, Huang Y, et al
    Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality.
    Eur Heart J. 2023;44:4324-4336.
    PubMed         Abstract available

  45. BARBATO E, Gallinoro E, Abdel-Wahab M, Andreini D, et al
    Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group.
    Eur Heart J. 2023;44:4340-4356.
    PubMed         Abstract available

  46. JOHNSON NP, Ahn JM
    Left main PCI: beware the circumflex!
    Eur Heart J. 2023;44:4337-4339.

  47. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
    Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
    Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.

  48. CREA F
    Hot topics in interventional cardiology: left main disease, heavily calcified coronary stenoses, and physiology-guided percutaneous coronary interventions.
    Eur Heart J. 2023;44:4295-4299.

    Instantaneous wave-free ratio compared with fractional flow reserve: time for rethinking current recommendations.
    Eur Heart J. 2023;44:4385-4387.

  50. BERRY C, McClure JD, Oldroyd KG
    Coronary revascularization guided by instantaneous wave-free ratio compared to fractional flow reserve: pooled 5-year mortality in the DEFINE-FLAIR and iFR-SWEDEHEART trials.
    Eur Heart J. 2023 Aug 27:ehad552. doi: 10.1093.

  51. EFTEKHARI A, Holck EN, Westra J, Olsen NT, et al
    Five-year major cardiovascular events are increased when coronary revascularization is guided by instantaneous wave-free ratio compared to fractional flow reserve: a pooled analysis of iFR-SWEDEHEART and DEFINE-FLAIR trials.
    Eur Heart J. 2023 Aug 27:ehad582. doi: 10.1093.
    PubMed         Abstract available

  52. BYRNE RA, Fremes S, Capodanno D, Czerny M, et al
    2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
    Eur Heart J. 2023;44:4310-4320.
    PubMed         Abstract available

    Int J Cardiol

  53. LINDOW T, Mokhtari A, Nystrom A, Koul S, et al
    Comparison of diagnostic accuracy of current left bundle branch block and ventricular pacing ECG criteria for detection of occlusion myocardial infarction.
    Int J Cardiol. 2023 Nov 4:131569. doi: 10.1016/j.ijcard.2023.131569.
    PubMed         Abstract available

    J Am Coll Cardiol

  54. LAU ES, Di Achille P, Kopparapu K, Andrews CT, et al
    Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:1936-1948.
    PubMed         Abstract available

  55. WILSON BH, Biga C, Marine JE
    Member Engagement Key to Transforming Cardiovascular Care for All.
    J Am Coll Cardiol. 2023;82:1967-1968.

  56. MORZE J, Rynkiewicz A
    C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    J Am Coll Cardiol. 2023;82:e191-e192.

  57. BURGER PM, Visseren FLJ, Dorresteijn JAN
    Reply: C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    J Am Coll Cardiol. 2023;82:e193.

  58. MAZIDI M, Wright N, Yao P, Kartsonaki C, et al
    Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease.
    J Am Coll Cardiol. 2023;82:1906-1920.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  59. YU M, Zhu ZF, Yang F, Yuan YF, et al
    Different anti-inflammatory drugs on high-sensitivity C-reactive protein in patients after percutaneous coronary intervention: A pilot randomized clinical trial.
    J Cardiovasc Pharmacol. 2023 Nov 7. doi: 10.1097/FJC.0000000000001509.
    PubMed         Abstract available

  60. KELLY MS, Dacey A, Siana A, Ojeda J, et al
    Efficacy and Safety of a polypill to reduce cardiovascular events: A review of clinical trials.
    J Cardiovasc Pharmacol. 2023 Nov 4. doi: 10.1097/FJC.0000000000001508.
    PubMed         Abstract available

  61. APOSTOLOS A, Travlos C, Tsioulos G, Chlorogiannis DD, et al
    Duration Of Dual Antiplatelet Treatment After Percutaneous Coronary Intervention In Patients With Diabetes: A Systematic Review And Meta-Analysis.
    J Cardiovasc Pharmacol. 2023 Nov 7. doi: 10.1097/FJC.0000000000001503.
    PubMed         Abstract available

  62. LI Y, Lin H, Tang H, Zhu K, et al
    The STING-IRF3 Signaling Pathway, Mediated by Endoplasmic Reticulum Stress, Contributes to Impaired Myocardial Autophagic Flux After Ischemia/Reperfusion.
    J Cardiovasc Pharmacol. 2023;82:389-399.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  63. ZENG C, Liu M, Zhang Y, Deng S, et al
    Association of Urine Albumin-to-Creatinine Ratio with Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad645. doi: 10.1210.
    PubMed         Abstract available

  64. YE J, Li K
    Letter to the Editor from Ye and Li: "Association of Circulating Very Long Chain Saturated Fatty Acids with Cardiovascular Mortality in NHANES 2015-2016".
    J Clin Endocrinol Metab. 2023 Nov 1:dgad647. doi: 10.1210.

  65. ROSENBERG EA, Seely EW
    Long-term Cardiovascular Disease After Adverse Pregnancy Outcomes.
    J Clin Endocrinol Metab. 2023 Nov 2:dgad600. doi: 10.1210.
    PubMed         Abstract available

  66. Correction to "Association of Circulating Very Long-Chain Saturated Fatty Acids With Cardiovascular Mortality in NHANES 2015 to 2016".
    J Clin Endocrinol Metab. 2023 Nov 2:dgad633. doi: 10.1210.

    J Clin Epidemiol

  67. MOZETIC DE BARROS V, Pacheco RL, Cabrera Martimbianco AL, Mozetic V, et al
    Definition and reporting of composite outcomes are often inadequate in randomized clinical trials on pharmacological interventions for coronary artery disease.
    J Clin Epidemiol. 2023 Nov 6:S0895-4356(23)00296.
    PubMed         Abstract available

    J Nucl Med

    Future of Radionuclide Myocardial Perfusion Imaging: Transitioning from SPECT to PET.
    J Nucl Med. 2023;64.

  69. THACKERAY JT, Lavine KJ, Liu Y
    Imaging Inflammation Past, Present, and Future: Focus on Cardioimmunology.
    J Nucl Med. 2023;64.
    PubMed         Abstract available

    J Thorac Cardiovasc Surg

  70. Discussion to: Long-term survival, cardiovascular, and functional outcomes after minimally invasive coronary artery bypass grafting in 566 patients.
    J Thorac Cardiovasc Surg. 2023 Nov 7:S0022-5223(23)00878.


  71. NISSEN SE, Nicholls SJ, Lincoff AM
    Bempedoic Acid for Primary Prevention of Cardiovascular Events-Reply.
    JAMA. 2023;330:1696-1697.

  72. GOLDSTEIN MR, Mascitelli L
    Bempedoic Acid for Primary Prevention of Cardiovascular Events.
    JAMA. 2023;330:1696.

  73. LARKIN H
    Here's What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.22276.

    Mayo Clin Proc

  74. MCKINNIE CM, Effron MB
    More Potent Antiplatelet Therapy in Acute Coronary Syndrome Patients With Prior Stroke: Proceed With Caution?
    Mayo Clin Proc. 2023;98:1590-1592.

  75. HUANG HY, Wang CC, Katz AJ, Lin SY, et al
    Ticagrelor vs Clopidogrel in Acute Myocardial Infarction Patients With a History of Ischemic Stroke.
    Mayo Clin Proc. 2023;98:1602-1612.
    PubMed         Abstract available

    Mol Cell Biochem

  76. MAINALI N, Li X, Wang X, Balasubramaniam M, et al
    Myocardial infarction elevates endoplasmic reticulum stress and protein aggregation in heart as well as brain.
    Mol Cell Biochem. 2023 Nov 3. doi: 10.1007/s11010-023-04856.
    PubMed         Abstract available

  77. NOOTHI SK, Ahmed MR, Agrawal DK
    Residual risks and evolving atherosclerotic plaques.
    Mol Cell Biochem. 2023;478:2629-2643.
    PubMed         Abstract available

    PLoS One

  78. LEOSDOTTIR M, Back M, Dahlbom L, Ekstrom M, et al
    Cohort profile: Data standards for cardiac rehabilitation structure and processes for the SWEDEHEART cardiac rehabilitation (SWEDEHEART-CR) registry.
    PLoS One. 2023;18:e0293840.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.